Clinical Trial

Evaluation of GRAMPA Score Measuring Motor Abilities of Elderly Patients

Study acronym: GRAMPA
Recruiting
View on ClinicalTrials.gov →
Summary
In the field of geriatrics, the Standardized Geriatric Approach (SGA) which is the benchmark for assessing elderly patients, consists of evaluating the medical, psychological and functional capacity dimensions of the elderly subject, among others. After a review of the literature, investigators were unable to find any scales that could study the ability to perform basic movements in a comprehensive and graded manner. Scores that do assess certain aspects of motor abilities are not comprehensive, and are often based on self-reporting by the elderly or their relatives : * The AGGIR grid assesses dependency on the basis of activities performed or not performed. In addition, all basic movements are grouped together in a single item, which does not provide detailed information on the capabilities of elderly people. * The ADL score assesses activities of daily living, based on what patients declare. Only one item concerns basic movements, without detailing them. * The Tinetti score and Time up and go do not assess all basic movements, and require the patient to be able to stand to provide relevant information, whereas many geriatrics patients are unable to stand. Thus, investigators created a score to assess motor abilities more comprehensively that will include the following basic movements: * Getting up in bed * Turning on one side in bed * Sitting at the edge of the bed * Stand up * Move around a small perimeter (bedroom) * Sitting up * Return to bed The main objective is to evaluate of this study is to determine the inter-rater reliability of the GRAMPA score in elderly patients hospitalized in a geriatrics department.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Trial Details
NCT Number NCT07236866
Lead Sponsor Groupe Hospitalier Mutualiste de Grenoble
Conditions Geriatric Assessment
Enrollment 55 participants
Start Date 2025-11-07
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18